KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) FCF Margin (2016 - 2026)

Abbott Laboratories' FCF Margin history spans 18 years, with the latest figure at 8.2% for Q1 2026.

  • On a quarterly basis, FCF Margin fell 80.0% to 8.2% in Q1 2026 year-over-year; TTM through Mar 2026 was 16.35%, a 63.0% increase, with the full-year FY2025 number at 16.68%, up 154.0% from a year prior.
  • FCF Margin hit 8.2% in Q1 2026 for Abbott Laboratories, down from 22.92% in the prior quarter.
  • Over the last five years, FCF Margin for ABT hit a ceiling of 22.92% in Q4 2025 and a floor of 6.29% in Q1 2024.
  • Historically, FCF Margin has averaged 15.06% across 5 years, with a median of 14.66% in 2022.
  • Biggest five-year swings in FCF Margin: plummeted -1107bps in 2023 and later skyrocketed 722bps in 2024.
  • Tracing ABT's FCF Margin over 5 years: stood at 17.01% in 2022, then surged by 31bps to 22.29% in 2023, then fell by -12bps to 19.57% in 2024, then rose by 17bps to 22.92% in 2025, then plummeted by -64bps to 8.2% in 2026.
  • Business Quant data shows FCF Margin for ABT at 8.2% in Q1 2026, 22.92% in Q4 2025, and 20.15% in Q3 2025.